Omada Health, which went public in June 2025, ended the year with 886,000, up 55% year over year
My goal is to provide accessible, expert support right here in our local community
Semaglutide is an FDA-approved medication that mimics the action of the GLP-1 hormone, which regulates appetite and food intake
While it doesn't predict traditional drug interactions, it does reveal your peptide-pathway predispositions, helping your provider optimize your semaglutide dosing and anticipate which patients may need closer metabolic monitoring when combining medications
[DOI] [PMC free article] [PubMed] [Google Scholar] 53.Zainuddin M.F., Nik Raikhan N.H., Othman N.H., Abdullah W.F.H
it is just a small amount of protein